Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

7,316 total articles

Cineverse Chief People Officer Acquires $50,000 in Class A Shares

Cineverse Chief People Officer Acquires $50,000 in Class A Shares

Cineverse Corp. (NASDAQ: CNVS) Chief People Officer Mark Torres purchased 25,000 shares of Class A Common Stock on February 17, 2026, at $2.00 per share, a transaction totaling $50,000. The purchase boosts Torres' direct stake to 183,274 shares and comes as the stock has recently rallied while the company pursues acquisitions and strategic product …

ADMA Biologics President Sells $337,679 in Stock; Exercises Options

ADMA Biologics President Sells $337,679 in Stock; Exercises Options

Adam S. Grossman, President and CEO of ADMA Biologics (ADMA), sold 21,000 shares on February 17, 2026, at $16.08 per share for proceeds of $337,679 and exercised options to acquire 15,000 shares at $5.40 each. The transactions were carried out under a Rule 10b5-1 plan established November 14, 2025. Following the trades Grossman holds significant di…

MediaAlpha CTO Sells Shares to Cover RSU Taxes as Board Bylaws Shift

MediaAlpha CTO Sells Shares to Cover RSU Taxes as Board Bylaws Shift

MediaAlpha Chief Technology Officer Kuanling Amy Yeh sold 12,000 Class A shares on February 13, 2026 under a pre-arranged Rule 10b5-1 plan to meet tax obligations tied to vested RSUs, and subsequently recorded the vesting of 15,317 RSU shares. Separately, the company updated its bylaws effective December 10, 2025 and confirmed the resignation of di…

Disc Medicine Legal Chief Sells Shares to Cover Tax Withholding as Regulatory Uncertainty Weighs on Stock

Disc Medicine Legal Chief Sells Shares to Cover Tax Withholding as Regulatory Uncertainty Weighs on Stock

Disc Medicine Chief Legal Officer Rahul Khara sold 2,853 shares on February 17, 2026 to meet tax withholding obligations tied to vested restricted stock units. The transaction occurred against a backdrop of share-price volatility and a regulatory setback for the company’s EPP candidate, bitopertin, as the FDA requested additional Phase 3 data.